Department of Thoracic Surgical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; First Department of Surgery, Hamamatsu University School of Medicine, Shizuoka, Japan.
Department of Thoracic Surgical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Clin Lung Cancer. 2023 Dec;24(8):743-752.e2. doi: 10.1016/j.cllc.2023.07.005. Epub 2023 Aug 4.
Various calculation models to predict surgical risk have been developed globally. These have been reported to be helpful for estimating the long-term prognosis. In Japan, a similar model for lung cancer surgery was developed in 2017; however, there have been no reports investigating its association with the long-term prognosis. The objective of this study was to assess the association of the model's predictions with the long-term prognosis.
In this retrospective single-institutional study, we analyzed lung cancer patients who underwent radical lobectomy between 2010 and 2016. We calculated the predicted rates of mortality (PRM) and composite outcomes of mortality with major morbidity (PRMM) in eligible patients (N = 1054) using this model and classified them into 2 classes (class A, PRM ≥0.8% and PRMM ≥5.9%; class B, others) based on their models' predictions. We assessed the prognostic impact and clinical utility of the model's predictions.
Class A included patients with significantly poorer postoperative overall survival than class B (log-rank, P < .001; hazard ratio, 3.160; 95% confidence interval, 2.390-4.178). Time-dependent receiver operating characteristic curve analyses revealed that the model's predictions correlated strongly with 1- and 2-year overall survival and decision curve analysis showed that they had high net benefits for prediction of those.
The Japanese risk calculator could stratify the long-term prognosis for lung cancer patients after surgery. This model may be a valuable tool not only for multidisciplinary thoracic oncology teams to discuss treatment strategies for high-risk cases but also for them to share the decision-making process with patients.
全球已开发出各种用于预测手术风险的计算模型,这些模型有助于估计长期预后。在日本,2017 年开发了一种类似的肺癌手术风险模型;然而,目前还没有报告调查其与长期预后的关系。本研究的目的是评估该模型的预测结果与长期预后的关系。
在这项回顾性单机构研究中,我们分析了 2010 年至 2016 年间接受根治性肺叶切除术的肺癌患者。我们使用该模型计算了符合条件的患者(n=1054)的死亡率预测率(PRM)和死亡率与主要发病率复合结局的预测率(PRMM),并根据模型的预测结果将其分为 2 类(A 类,PRM≥0.8%和 PRMM≥5.9%;B 类,其他)。我们评估了模型预测的预后影响和临床实用性。
A 类患者的术后总生存率明显低于 B 类患者(对数秩检验,P<0.001;风险比,3.160;95%置信区间,2.390-4.178)。时间依赖性接受者操作特征曲线分析显示,该模型的预测结果与 1 年和 2 年的总生存率密切相关,决策曲线分析显示,它们在预测这些生存率方面具有较高的净收益。
日本风险计算器可以对肺癌患者手术后的长期预后进行分层。该模型不仅可以为多学科胸肿瘤团队讨论高危病例的治疗策略提供有价值的工具,还可以为团队与患者共享决策过程提供有价值的工具。